- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 233/90 - Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Patent holdings for IPC class C07D 233/90
Total number of patents in this class: 442
10-year publication summary
|
33
|
46
|
25
|
35
|
33
|
21
|
30
|
28
|
24
|
17
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Koei Chemical Company, Limited | 57 |
13 |
| Bristol-myers Squibb Company | 4764 |
10 |
| Bayer AG | 3562 |
9 |
| FUJIFILM Corporation | 30628 |
9 |
| Nippon Soda Co., Ltd. | 886 |
9 |
| Eonhf, Inc. | 45 |
8 |
| Hoffmann-La Roche Inc. | 3825 |
7 |
| Boehringer Ingelheim International GmbH | 4485 |
7 |
| The General Hospital Corporation | 4879 |
7 |
| Arkema France | 4250 |
7 |
| Janssen Pharmaceutica N.V. | 3160 |
6 |
| Bayer Cropscience AG | 1836 |
6 |
| Taisho Pharmaceutical Co., Ltd. | 847 |
6 |
| Hydro-Quebec | 633 |
5 |
| Imago Biosciences, Inc. | 39 |
5 |
| Theravance Biopharma R&D IP, LLC | 360 |
5 |
| F. Hoffmann-La Roche AG | 7800 |
4 |
| Takeda Pharmaceutical Company Limited | 2699 |
4 |
| Daiichi Sankyo Company, Limited | 1891 |
4 |
| Exelixis, Inc. | 395 |
4 |
| Other owners | 307 |